MIRA INFORM REPORT

 

 

Report Date :

08.01.2011

 

IDENTIFICATION DETAILS

 

Name :

MEHTA PHARMACEUTICALS INDUSTRIES

 

 

Registered Office :

315/ 318, Janki Centre, Plot No.29, Shah Industrial Estate, Off Vira Desai Road, Andheri (West), Mumbai – 400 053, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2009

 

 

Date of Incorporation :

25.02.1974

 

 

Com. Reg. No.:

11/24-05068

 

 

IEC No.:

0388036591

 

 

PAN No.:

[Permanent Account No.]

AAEFM3693B

 

 

Legal Form :

Partnership Concern with an Unlimited Liability of the Partners.

 

 

Line of Business :

Manufacturer, Trader and Exporter of Bulk Drugs.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 745000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established partnership concern having satisfactory track. Trade relations are fair. Business is active. Payments are reported to be usually correct as per commitment.

 

The concern can be considered for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Vinay Shah

Designation :

Accounts Manager

Date :

08.01.2011

 

 

LOCATIONS

 

Registered/ Corporate

Office :

315/ 318, Janki Centre, Plot No.29, Shah Industrial Estate, Off Vira Desai Road, Andheri (West), Mumbai – 400 053, Maharashtra, India

Tel. No.:

91-22-61459500/ 66926545/ 26730750

Fax No.:

91-22-66925901/ 26730129

E-Mail :

exports@mehtapharma.com

atul.mehta@mehtapharma.com

harshad.mehtapharma@gmail.com

dev.mehta@mehtapharma.com

export@mehtapharma.com

cram@mehtapharma.com

Website :

www.mehtapharma.com

Area :

2800 Sq. Ft

Location :

Owned

 

 

Factory 1 :

Unit No.2, Chandansar, Kopri Village Naka, Veer Savarkar Road, Virar (East), District – Thane, Maharashtra, India

Tel. No.:

91-250-2527626/ 2527131/ 2528526

Fax No.:

91-250-2529463

Location :

Owned

 

 

Factory 2 :

Behind REMI Group, Near Plot No. N-211, Village Kumbhavali, Adjacent to MIDC Area, Tarapur, Taluka-Palghar, Dist-Thane, Pin-401 506, Maharashtra, India

Tel. No.:

91-2525-645438/ 39

Fax No.:

91-2525-275780/ 90

 

 

Warehouse :

National Transport Company, Godown No.-A3, Jaybagwan Compound, Bhiwandi, India

Tel No.:

91-2522-349939

Area :

2150 Sq. Ft

Location :

Rented

 

 

PARTNERS

 

Name :

Mr. Harshadra P Mehta

Designation :

Partner

Address :

B-201/202, Mohan Villa, 2nd Floor, Bajaj Road, Mumbai – 400056, Maharashtra, India

Date of Birth/Age :

66 years

Qualification :

Inter Science

Experience :

41 years

 

 

Name :

Mr. Surshchadra P Mehta

Designation :

Partner

Address :

“Om Kailash” Bunglow, Vartak Road, Virara (West), District Thane – 401303, Maharashtra, India

Date of Birth/Age :

63 years

Qualification :

SSC

Experience :

41 years

 

 

Name :

Mr. Devendra H Mehta

Designation :

Partner

Date of Birth/Age :

42 years

Address :

B-201/202, Mohan Villa, 2nd Floor, Bajaj Road, Mumbai – 400056, Maharashtra, India

Qualification :

BSC and Management Studies

Experience :

18 years

 

 

Name :

Mr. Yogin H Mehta

Designation :

Partner

Address :

B-201/202, Mohan Villa, 2nd Floor, Bajaj Road, Mumbai – 400056, Maharashtra, India

Date of Birth/Age :

39years

Qualification :

B Com

Experience :

15 years

 

 

Name :

Mr. Chetan S Mehta

Designation :

Partner

Address :

“Om Kailash” Bunglow, Vartak Road, Virara (West), District Thane – 401303, Maharashtra, India

Date of Birth/Age :

38 years

Qualification :

B Com

Experience :

12 years

 

 

Name :

Mr. Atul S Mehta

Designation :

Partner

Address :

“Om Kailash” Bunglow, Vartak Road, Virara (West), District Thane – 401303, Maharashtra, India

Date of Birth/Age :

36 years

Qualification :

B.SC

Experience :

10 years

 

 

KEY EXECUTIVES

 

Name :

Mr. Vinay Shah

Designation :

Account Manager

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Trader and Exporter of Bulk Drugs.

 

 

Products :

·         Aminophyliine

·         Amlodipine Besylate

·         Calcium Sennoside

·         Choline BiTartarate

·         Chlorampheniramine Maleate

·         Choline Theophyllinate

·         Chlorhexidine Base and Salt

·         Di – Sodium Hydrogen Citrate

·         Erythromycin Base

 

 

Exports :

 

Countries :

·         Indonesia

·         Bangladesh

·         Pakistan

 

 

Imports :

 

Products :

·         Intermediates 

·         Raw Materials

Countries :

·         China

·         Japan

 

 

Terms :

 

Selling :

L/C, Cash / Credit (30-60-90 days)

 

 

Purchasing :

L/C, Cash / Credit (60-90 days)

 

 

GENERAL INFORMATION

 

Customers :

End Users and Retailers

 

·         PT. Tigaka Distrindo Perkasa

JL. Tanah Abang II/ 37, Jakarta – 10160, Indonesia

 

·         Parke Davis and Company Limited

B-2, SITE, Karchi – 75700, Pakistan

 

·         Sanofi Aventis Bangladesh limited

6/2/A, Segun Bagicha, Dhaka – 1000, Bangladesh

 

 

No. of Employees :

60 (Office – 15 and Factory – 45) (Approximately)

 

 

Bankers :

·         Central Bank of India,

Churchgate Branch, Mumbai, Maharashtra, India. 

 

 

Facilities :

Non Fund Base – Rs.255.000 Millions

Fund Base – Rs.85.000 Millions

 

 

 

Banking Relations :

---

 

 

Auditors :

 

Name :

Kantilal M. Shah and Company

Chartered Accountant

Address :

25 Vasant NNAS, Nehru Road, Vile Parle (East), Mumbai – 400057, Maharashtra, India

Tel No.:

91-22-26143012

Fax No.:

91-22-26143012

 

 

Associates/Subsidiaries :

·         Mehta API Private Limited

Address: Gut No.546, Behind Remi Group, Nrear Plot No.211, Village Kumbahvali, Taluk Palghar District Thane - 401506, Maharashtra, India

Line of Business: Manufacturer of APL’s and Advance Intermediates.

Tel No.: 91-2525-64543/ 39

Fax No.: 91-2525-275780/ 90

 

·         Mehta Chemicals

Address: 315/318, Janki Center, Plot No.29, Shah Industrial Estate, Off. Vira Desai Road, Andheri (West), Mumbai – 400053, Maharashtra, India.

Line of Business: Trading of Chemicals.

 

·         Santosh Pharma

Address: 315/318, Janki Center, Plot No.29, Shah Industrial Estate, Off. Vira Desai Road, Andheri (West), Mumbai – 400053, Maharashtra, India.

Line of Business: Trading of Bulk Drugs.

 

 

CAPITAL STRUCTURE

 

 

Particulars

31.03.2009

Rs. in Millions

Mr. H. P. Mehta

66.738

Mr. S. P. Mehta

66.013

Mr. D. H. Mehta

13.078

Mr. Y. N. Mehta

13.762

Mr. C S Mehta

13.286

Mr. A. S. Mehta

13.489

 

 

Total

186.366

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2009

 

31.03.2008

 

31.03.2007

SHAREHOLDERS FUNDS

 

 

 

1] Partner’s Fund

186.366

179.207

156.432

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

0.000

0.000

0.000

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

186.366

179.207

156.432

LOAN FUNDS

 

 

 

1] Secured Loans

34.145

83.201

43.089

2] Unsecured Loans

16.425

16.965

31.438

TOTAL BORROWING

50.570

100.166

74.527

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

236.936

279.373

230.959

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

21.191

21.280

22.477

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.006

0.006

0.006

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

91.771

153.745

123.659

 

Sundry Debtors

162.171

251.421

131.958

 

Cash & Bank Balances

2.460

0.965

0.354

 

Other Current Assets

7.601

10.291

9.104

 

Loans & Advances

69.113

56.845

58.862

Total Current Assets

333.116

473.267

323.937

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

117.377

215.180

115.461

 

Provisions

0.000

0.000

0.000

Total Current Liabilities

117.377

215.180

115.461

Net Current Assets

215.739

258.087

208.476

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

236.936

279.373

230.959

 

 


PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2009

 

31.03.2008

 

31.03.2007

Sales Turnover and Related Income

946.333

791.860

780.680

Other Income

25.656

20.084

12.231

Total Income

971.989

811.944

792.911

 

 

 

 

Profit/(Loss) Before Tax

43.052

38.627

47.366

Provision for Taxation

0.295

0.216

0.000

Profit/(Loss) After Tax

42.757

38.411

47.366

 

 

 

 

Expenditures :

 

 

 

 

Raw Material, Packing Materials and Goods Consumption

807.342

673.923

650.965

 

Manufacturing Expenses

33.671

39.582

39.699

 

Administrative Expenses

16.533

16.241

16.479

 

Payments to and Provision for Employees

8.748

8.743

5.613

 

Interest and Finance Charges

41.950

16.536

13.274

 

Depreciation & Amortization

2.669

2.833

2.714

 

Other Expenses

18.024

15.459

16.801

Total Expenditure

928.937

773.317

745.545

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2009

 

31.03.2008

 

31.03.2007

PAT / Total Income

(%)

4.39

4.73

5.97

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

4.54

4.88

6.07

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

12.15

7.68

13.67

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.23

0.22

0.30

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.90

1.76

1.21

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.83

2.23

2.81

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Details of Sundry Creditors: Not Available

 

TRADE REFERENCES:

 

  • Pragati Raw Pharma Private Limited – Santacruz
  • IPCA Laboratories Limited – Kandivali
  • Phizer India Limited

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.37

UK Pound

1

Rs.70.04

Euro

1

Rs.58.93

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.